| 000 | 00920 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513051243.0 | ||
| 264 | 0 | _c19940322 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(94)91518-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarnett, D B | |
| 245 | 0 | 0 |
_aBeta-blockers in heart failure: a therapeutic paradox. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 1994 |
||
| 300 |
_a557-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xphysiopathology |
| 773 | 0 |
_tLancet (London, England) _gvol. 343 _gno. 8897 _gp. 557-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(94)91518-0 _zAvailable from publisher's website |
| 999 |
_c7905659 _d7905659 |
||